Faculty Opinions recommendation of Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.

2020 ◽  
Author(s):  
Riichiro Abe
Keyword(s):  
Combination Therapy ◽  
Toxic Epidermal Necrolysis ◽  
Intravenous Immunoglobulin ◽  
Acute Treatment ◽  
Stevens Johnson Syndrome ◽  
Johnson Syndrome

Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis

Burns ◽  
2019 ◽  
Vol 45 (7) ◽  
pp. 1634-1638 ◽  
Author(s):  
Christopher H. Pham ◽  
T. Justin Gillenwater ◽  
Eric Nagengast ◽  
Meghan C. McCullough ◽  
David H. Peng ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Toxic Epidermal Necrolysis ◽  
Intravenous Immunoglobulin ◽  
Acute Treatment ◽  
Stevens Johnson Syndrome ◽  
Johnson Syndrome

A 2-Year-Old Girl with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin

2005 ◽  
Vol 22 (4) ◽  
pp. 317-320 ◽  
Author(s):  
Ercan Arca ◽  
Osman Kose ◽  
A. Hakan Erbil ◽  
Mustafa Nisanci ◽  
Ahmet Akar ◽  
...  
Keyword(s):  
Toxic Epidermal Necrolysis ◽  
Intravenous Immunoglobulin ◽  
Stevens Johnson Syndrome ◽  
Johnson Syndrome

Antiepileptic combination therapy with Stevens‐Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database

Epilepsia ◽  
2020 ◽  
Vol 61 (9) ◽  
pp. 1979-1989 ◽  
Author(s):  
Yoshihiro Noguchi ◽  
Mirai Takaoka ◽  
Tsuyoshi Hayashi ◽  
Tomoya Tachi ◽  
Hitomi Teramachi
Keyword(s):  
Combination Therapy ◽  
Toxic Epidermal Necrolysis ◽  
Stevens Johnson Syndrome ◽  
Johnson Syndrome ◽  
Pharmacovigilance Database

scholarly journals Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis in the USA

2021 ◽  
Vol 8 ◽  
Author(s):  
Derek Metcalfe ◽  
Omer Iqbal ◽  
James Chodosh ◽  
Charles S. Bouchard ◽  
Hajirah N. Saeed
Keyword(s):  
Chronic Disease ◽  
Toxic Epidermal Necrolysis ◽  
Acute Treatment ◽  
Management Strategies ◽  
Ocular Disease ◽  
Stevens Johnson Syndrome ◽  
Amniotic Membrane Transplantation ◽  
Ocular Involvement ◽  
Johnson Syndrome ◽  
The Usa

Stevens Johnson syndrome and toxic epidermal necrolysis are on a spectrum of a severe, immune-mediated, mucocutaneous disease. Ocular involvement occurs in the vast majority of cases and severe involvement can lead to corneal blindness. Treatment in the acute phase is imperative in mitigating the severity of chronic disease. Advances in acute treatment such as amniotic membrane transplantation have shown to significantly reduce the severity of chronic disease. However, AMT is not a panacea and severe chronic ocular disease can and does still occur even with aggressive acute treatment. Management of chronic disease is equally critical as timely intervention can prevent worsening of disease and preserve vision. This mini-review describes the acute and chronic findings in SJS/TEN and discusses medical and surgical management strategies.

Sign in / Sign up

Export Citation Format

Share Document